Skip to Main Content

Advertisement

Skip Nav Destination

Issues

Highlights from the Literature

Spotlight

Review

Research Articles

Our study demonstrates the impact of diet on breast cancer risk, focusing on the interplay between diet, the gut microbiome, and mammary gland inflammation.

We reveal that administering canakinumab is associated with a decrease in non-hematological malignancies among patients with clonal hematopoiesis (CH) mutations. These findings underscore canakinumab’s potential in preventing cancer and provide proof of IL1β blockade collaborating with CH mutations to enhance its clinical benefits.

Close Modal

or Create an Account

Close Modal
Close Modal